Taxotere
Links shared publicly online about this topic
Generic Taxotere Gets FDA Marketing Okay
breastcancer.org — “Generic Taxotere Gets FDA Marketing Okay” View full resource at breastcancer.org
Most Recently Shared on March 21, 2011 at 11:58 am By:
Good for the medical bills - BC survivors - generic form of Taxotere approved by FDA http://bit.ly/hOI5HF #wcancer #bcsm
Mylan pulls EU application for generic Taxotere | Reuters
reuters.com — “LONDON, March 15 (Reuters) - Mylan has withdrawn its application to market a generic version of Sanofi-Aventis's cancer drug in Europe, after adverse feedback from regulators.” View full resource at reuters.com
Most Recently Shared on March 15, 2010 at 12:58 pm By:
Reuters: Mylan pulls EU application for generic #Taxotere. http://bit.ly/a0UhNE
Single vial formulation of Taxotere approved - ONA
oncologynurseadvisor.com — “Sanofi-aventis announced that the FDA has approved a one-vial formulation of Taxotere (docetaxel injection concentrate).” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 5, 2010 at 2:55 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Single vial formulation of Taxotere approved http://goo.gl/fb/U7lXX
Neoadjuvant Taxotere and ADT Well Tolerated in High-risk Prostate Cancer
professional.cancerconsultants.com — “Neoadjuvant Taxotere and ADT Well Tolerated in High-risk Prostate Cancer” View full resource at professional.cancerconsultants.com
Most Recently Shared on October 27, 2009 at 8:51 pm By:
Neoadjuvant Taxotere® and ADT Well Tolerated in High-risk Prostate Cancer http://bit.ly/4nvNC3
Dad starting chemo-advice on taxotere? | Cancer Survivors Network
csn.cancer.org — “Dad starting chemo-advice on taxotere? | Cancer Survivors Network” View full resource at csn.cancer.org
Most Recently Shared on October 21, 2010 at 4:56 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Dad starting chemo-advice on taxotere?: My dad is 65 and has prostate cancer that has spread to his bones. Lupron ... http://bit.ly/dv9lhO
Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere
professional.cancerconsultants.com — “Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere” View full resource at professional.cancerconsultants.com
Most Recently Shared on March 5, 2010 at 3:38 pm By:
Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of ... http://bit.ly/asi3l0
Medical News: Generic Taxotere Gets FDA Marketing Okay - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved marketing of generic docetaxel -- previously under patent and sold as Taxotere by sanofi-aventis.” View full resource at medpagetoday.com
Most Recently Shared on March 11, 2011 at 6:29 pm By:
Generic Taxotere Gets FDA Marketing Okay http://bit.ly/hTgmQ6
UPDATE 1-U.S. court invalidates Sanofi's Taxotere patents | Reuters
reuters.com — “* Ruling invalidates two patents * Clears the way for generic competition by year-end (Adds Sanofi comment in paragraph six, updates stock prices) By Tom Hals WILMINGTON, Del., Sept 28 (Reuters)” View full resource at reuters.com
Most Recently Shared on September 28, 2010 at 7:55 pm By:
Reuters: U.S. court invalidates Sanofi's Taxotere patents. http://bit.ly/9U3FGS
Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE CANCER INFOLINK
prostatecancerinfolink.net — “Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE CANCER INFOLINK” View full resource at prostatecancerinfolink.net
Most Recently Shared on November 11, 2009 at 9:05 pm By:
Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE ... http://bit.ly/AbW5u
UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing | Reuters
reuters.com — “* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA * Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7) WASHINGTON, May” View full resource at reuters.com
Most Recently Shared on May 14, 2009 at 2:02 pm By:
eyeonfda Pharma and Health Lawyer
FDA cites Sanofi on breast cancer drug marketing http://twurl.nl/n7jjg0
Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapy
medicalnewstoday.com — “Taxanes, a group of cancer drugs that includes paclitaxel (taxol®) and docetaxel (taxotere®), have become front-line therapy for a variety of metastatic cancers. but as with many chemother” View full resource at medicalnewstoday.com
Most Recently Shared on January 28, 2010 at 1:14 pm By:
Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapy http://mnt.to/3wRc #cancer
ResearchPoint & Azaya Therapeutics Announce First Patient Enrolled In Phase I Clinical Study
medicalnewstoday.com — “Researchpoint and azaya therapeutics, inc. are proud to announce the study initiation and enrollment of the first patient in the phase i clinical study of ati-1123, a new formulation of docetaxel.” View full resource at medicalnewstoday.com
Most Recently Shared on January 28, 2010 at 9:37 am By:
ResearchPoint & Azaya Therapeutics Announce First Patient Enrolled In Phase I Clinical Study ResearchPoint and Azaya .. http://bit.ly/9CWUxF
Hospira generic of Sanofi cancer drug approved | Reuters
reuters.com — “NEW YORK (Reuters) - Hospira Inc won approval for the first U.S. generic version of Sanofi-Aventis SA's big-selling Taxotere cancer drug, sending Hospira shares up 2 percent.U.S. sales of Taxotere, an” View full resource at reuters.com
Most Recently Shared on March 9, 2011 at 5:29 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Hospira gets approval for generic of Sanofi cancer drug http://ow.ly/1bGFaY
Hospira gets approval for generic of Sanofi cancer drug | Reuters
reuters.com — “NEW YORK (Reuters) - Hospira Inc won approval for the first U.S. generic version of Sanofi-Aventis SA's big-selling Taxotere cancer drug, sending Hospira shares up 2.5 percent.U.S. sales of Taxotere,” View full resource at reuters.com
Most Recently Shared on March 9, 2011 at 4:19 pm By:
Hospira gets approval for generic of Sanofi cancer drug http://reut.rs/hQ2FuK
Medical News: AACR: Drug Combo Effective in Cancer Models - in Meeting Coverage, AACR from MedPage Today
medpagetoday.com — “WASHINGTON -- Researchers suggest that the combination of the thalidomide analogue, lenalidomide (Revlimid) and the taxane docetaxel (Taxotere) may be able to improve survival in cell and animal model” View full resource at medpagetoday.com
Most Recently Shared on April 23, 2010 at 3:15 pm By:
AACR: Drug Combo Effective in Cancer Models (CME/CE) http://bit.ly/aBKo60
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Jody Schoger
Free-lance writer, cancer survivor & advocate, cyclist, quilter, art lover and reader. Have dog, we travel.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
